DE
Journey Medical Corporation
DERM · NASDAQ
$7.31 -0.68% (-$0.05)
1M +8.08%
Market Cap $195.1M
P/E Ratio -
Div. Yield -
ROE 20.23%
Piotroski F-Score Moderate
4/9Valuation
19 /100
Expensive P/B 6.08x
EV/EBITDA 105.48x
P/S 2.86x
Growth
22 /100
Declining Book val. growth 23.32%
Rev. growth 5.66%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 4.41%
Gross margin 62.24%
FCF margin 10.99%
Quality
9 /100
Poor ROA 6.21%
ROIC 5.23%
Asset turnover 0.69x
Debt
66 /100
Moderate Int. coverage -0.66x
Debt/Equity 0.80x
Net debt/EBITDA -0.06x
Stability
35 /100
Moderate EPS volatility 177.50%
Beta 1.10x
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o DERM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Claude Maraoui
Employees
58
Headquarters
Scottsdale
Nadchodzące wydarzenia
11 LIS
Earnings
Upcoming earnings report